1. Home
  2. Browse
  3. Practice
  4. Legal & Licensing

Legal & Licensing

346 - 360 of 504 Results
Sort Results:
Commentary: New Formulation: Oxecta (Oxycodone) October 2011
Other: Lazanda REMS Program October 2011
Other: Lazanda REMS training and enrollment is available at www.LazandaREMS.com October 2011
Chart: Fentanyl Products for Breakthrough Pain October 2011
Article: More drug shortages mean you'll have to help more patients switch to an appropriate alternative September 2011
Commentary: Drug Shortages: Making the Best of It August 2011
Other: FDA Drug Info Rounds—Drug Shortages (December 2010) August 2011
Patient Education: Safe Use of Acetaminophen (Tylenol) August 2011
Commentary: CPE Monitor Will Change How You Report CE August 2011
Article: confusing the news about Avandia and Actos July 2011
Commentary: Actos (Pioglitazone) and Increased Risk of Bladder Cancer July 2011
Article: A new Risk Evaluation and Mitigation Strategy (REMS) will aim to reduce the misuse of long-acting opioids June 2011
Commentary: REMS for Long-Acting and Extended-Release Opioids June 2011
Article: new risk management programs with Abstral (AB-stral) and other immediate-release fentanyl products May 2011
Commentary: New Formulation: Abstral (Fentanyl) Sublingual Tablets May 2011